Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is influenced by various factors and may be managed by restoring gut health and using new therapies.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Obesity worsens PCOS symptoms, and PCOS may lead to more weight gain; managing both requires a holistic approach that includes mental health.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Targeting hair follicles can improve skin treatments and reduce side effects.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Hair loss requires customized treatments based on its various causes and types.